MLYS Dividend History & Analysis | 0% Yield

MLYS has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of September 2025, Mineralys Therapeutics (MLYS) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
ABBV 389,032 M 4.01% 11.1%
GILD 146,242 M 2.91% 5.88%
AMGN 152,211 M 3.34% 4.43%
HLN 44,172 M 1.88% 2.56%
BIOG-B 1,118 M 1.87% 1.80%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
BIOG-B 1,118 M 20.4% 92.8%
GRFS 8,687 M 50.6% 60.7%
SECARE 679 M 10.4% 100%
AMGN 152,211 M 7.06% 100%
ABBV 389,032 M 5.61% 100%

Similar Stocks with Attractive Dividends - Compare MLYS Dividends with its Peer-Group

ABBV
AbbVie
4.01% Yield
AMGN
Amgen
3.34% Yield
GILD
Gilead Sciences
2.91% Yield
VOX
Voxel S.A.
1.80% Yield

MLYS Dividend History: as of September 2025

No dividends paid yet.

MLYS Dividend FAQ

Mineralys Therapeutics, Inc. is a biotechnology company listed on NASDAQ under the ticker symbol MLYS. The companys common stock is traded in the US market, and its market capitalization stands at approximately $962.61 million.

What is the Dividend Yield of MLYS?

As of September 2025, MLYS`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 36.21.

Does MLYS pay a dividend?

As of September 2025 MLYS does not pay a dividend.

How often does MLYS pay dividends?

Over the last 12 months, MLYS has issued dividend payments.

Will MLYS pay dividends in 2025?

The next Ex-Dividend date for Mineralys Therapeutics (MLYS) is currently unknown.

What is the next Ex-Dividend Date for MLYS?

The next Ex-Dividend date for Mineralys Therapeutics (MLYS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of MLYS?

MLYS's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of MLYS?

MLYS's 5-Year Yield on Cost is -%. If you bought MLYS's shares at 16.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of MLYS?

MLYS Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does MLYS have a good Dividend Yield?

MLYS`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of MLYS?

The Dividend Payout Ratio of MLYS is unknown.

What is the Dividend Rating of MLYS?

MLYS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

MLYS Outstanding Shares Analysis

What is the Trend in MLYS`s Outstanding Shares (CAGR)?

Mineralys Therapeutics`s outstanding shares have increased by approximately 25.93% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Mineralys Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2020 5,000,000
2021 5,059,800 +1.2%
2022 5,210,500 +2.98%
2023 40,093,200 +669.47%
2024 49,957,900 +24.6%
2025 65,451,300 +31.01%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-09-16 04:11